A Phase 1, Randomized, Balanced, Single-Dose, Two-Period, Two-Sequence, Crossover, Open-Label Study of the Effect of Food on the Bioavailability and Pharmacokinetics of PA-824 Tablets in Healthy Adult Subjects
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Pretomanid (Primary)
- Indications Tuberculosis
- Focus Pharmacokinetics
Most Recent Events
- 18 Apr 2013 New trial record